Zamirowski Justin 4
4 · Better Therapeutics, Inc. · Filed Apr 4, 2022
Insider Transaction Report
Form 4
Zamirowski Justin
Chief Commercial Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-04-01+86,800→ 86,800 totalExercise: $1.97Exp: 2032-03-31→ Common Stock (86,800 underlying)
Footnotes (1)
- [F1]The stock option vests as to 1/4 of the shares subject to the stock option on April 1, 2023 and the remaining shares vest in 36 equal monthly installments thereafter, provided the Reporting Person continues to have a service relationship with Issuer on each vesting date. The stock option was granted on April 1, 2022.